Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern

aCharite-Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Germany

bDepartment of Public Health and Clinical Medicine, Umea University, Sweden

cFaculty of Biology and Medicine, University of Lausanne, Switzerland

dClinica Medica, University Milano-Bicocca, Milan, Italy

eDepartment of Hypertension, National Institute of Cardiology, Warsaw, Poland

fInstitute for Clinical Medicine, University of Oslo

gDepartments of Cardiology and Nephrology, Ullevaal Hospital, Oslo, Norway

hOC 2 Medicina, ASST Spedali Civili di Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Italy

iDepartment of Cardiology, General Hospital of Athens “Laiko”

jFirst Department of Cardiology, Medical School, University of Athens, Hippokration Hospital, Athens, Greece

kUniversity Milano-Bicocca, Italy

Correspondence to Reinhold Kreutz, MD, Universitätsmedizin Berlin - Charité Campus Mitte, Institute of Clinical Pharmacology and Toxicology, Charitéplatz 1, 10117 Berlin, Germany. E-mail: [email protected]

留言 (0)

沒有登入
gif